123
Participants
Start Date
January 3, 2022
Primary Completion Date
September 6, 2022
Study Completion Date
September 6, 2022
Pilocarpine Ophthalmic Topical Cream, Dose 1
Pilocarpine Ophthalmic Topical Cream, Dose 1
Pilocarpine Ophthalmic Topical Cream, Dose 2
Pilocarpine Ophthalmic Topical Cream, Dose 2
Pilocarpine Ophthalmic Topical Cream, Dose 3
Pilocarpine Ophthalmic Topical Cream, Dose 3
Placebo Ophthalmic Topical Cream
Placebo Ophthalmic Topical Cream
Glaukos Investigator, Rochester
Glaukos Investigator, Memphis
Glaukos Investigator, Louisville
Glaukos Investigator, Houston
Glaukos Investigator, San Antonio
Glaukos Investigator, Chandler
Glaukos Investigator, Sun City
Glaukos Investigator, Glendale
Glaukos Investigator, Newport Beach
Glaukos Investigator, Petaluma
Lead Sponsor
Glaukos Corporation
INDUSTRY